Innovative Industrial, GrowGen Post S&P 500 Gains on May Rally
Two cannabis ancillary stocks climbed alongside the broader index as investors rotated into real estate and cultivation equipment plays.

Close-up of a smartphone displaying stock market data over a dollar bill on a desk.
IIPR and GrowGen Rally Alongside Broader Market
Innovative Industrial Properties (IIPR) and GrowGeneration (GRWG) both posted gains in late May 2026, moving in tandem with the S&P 500's upward trajectory. IIPR, the largest cannabis-focused real estate investment trust, saw its share price climb as institutional investors returned to dividend-yielding REITs. GrowGen, which operates hydroponic and organic gardening centers serving cannabis cultivators, benefited from renewed interest in cultivation infrastructure stocks.
The cleanest read on this move is sector rotation. Cannabis ancillary equities are catching a bid after months of underperformance. Investors want exposure without touching plant-touching operators still constrained by federal prohibition. Both stocks have historically tracked the S&P 500 more closely than MSO equities, which remain OTC-listed and subject to 280E tax burdens.
IIPR's business model insulates it from direct cannabis operations while capturing rent revenue from state-legal cultivators through sale-leaseback agreements with licensed operators. GrowGen supplies cultivation equipment to both cannabis and traditional agriculture customers, offering a similar regulatory buffer. That positioning has made both stocks attractive to institutional investors who can't hold plant-touching equities.
Cannabis REIT Performance Reflects Broader Real Estate Trends
IIPR's May gains mirror a broader recovery in real estate investment trusts as interest-rate expectations stabilized. The REIT sector had lagged through early 2026 amid Fed policy uncertainty, but softening rate rhetoric in Q2 lifted dividend-focused equities. IIPR's dividend yield, historically above 7%, remains a draw for income-focused portfolios.
The company's portfolio spans 108 properties across 19 states, with concentrations in Pennsylvania, Illinois, and California. Occupancy rates above 95%. Rent collections holding steady despite operator bankruptcies in smaller markets. Recent earnings calls emphasized that operational stability, which has kept IIPR on institutional radars even as cannabis equities broadly struggled.
For full background on this story, see the CannIntel topic hub on Cannabis REITs & Stock Performance.
GrowGen's Climb Tied to Cultivation Expansion Cycles
GrowGeneration's stock movement reflects optimism around a new cultivation buildout cycle as Ohio, Kentucky, and Minnesota prepare adult-use launches. The retailer operates 34 stores across 13 states, selling grow lights, nutrients, environmental controls, and other equipment to licensed cultivators and home growers. Revenue had contracted through 2024-2025 as operators delayed capital expenditures, but management signaled on its Q1 2026 earnings call that equipment sales were stabilizing.
The company's pivot toward B2B sales has improved margins but increased revenue volatility tied to state licensing timelines, since it's now supplying large-scale cultivators rather than home hobbyists. New-market openings typically drive equipment purchases 6-12 months before retail sales commence. That positions GrowGen to benefit from the current wave of adult-use rollouts.
Analyst consensus estimates GrowGen's 2026 revenue at $185 million, down from a 2021 peak of $422 million but stabilizing after two years of contraction. The stock's correlation with the S&P 500 suggests it's trading more on macro sentiment than cannabis-specific fundamentals.
Frequently asked questions
Why did Innovative Industrial Properties and GrowGen rise in May 2026?
Both stocks climbed alongside the S&P 500's late-May rally, benefiting from sector rotation into dividend-yielding REITs and cannabis ancillary plays. IIPR's stable rent collections and GrowGen's positioning ahead of new-market launches attracted institutional buyers seeking cannabis exposure without plant-touching risk.
What is Innovative Industrial Properties' business model?
IIPR operates as a cannabis-focused REIT, acquiring properties from licensed operators and leasing them back under long-term agreements. The company owns 108 properties across 19 states, generating rental income while avoiding direct cannabis operations. Its dividend yield historically exceeds 7%.
How does GrowGeneration make money in the cannabis industry?
GrowGen operates 34 hydroponic and organic gardening stores selling cultivation equipment—grow lights, nutrients, environmental controls—to licensed cannabis operators and home growers. The company has shifted focus toward B2B sales to large-scale cultivators, improving margins but tying revenue to state licensing cycles.
Do IIPR and GrowGen face the same regulatory risks as MSOs?
No. Both companies avoid plant-touching operations, insulating them from federal cannabis prohibition. IIPR collects rent from operators, and GrowGen sells equipment used in both cannabis and traditional agriculture. That positioning allows them to list on major exchanges and attract institutional capital unavailable to OTC-listed MSOs.
What states are driving GrowGen's current growth outlook?
Ohio, Kentucky, and Minnesota are preparing adult-use launches, typically triggering cultivation buildouts 6-12 months before retail sales begin. GrowGen supplies equipment during these expansion phases, positioning the company to benefit from the current wave of new-market openings despite broader revenue contraction since 2021.
Sources
The cannabis newsletter you forward to your team.
Federal policy, market data, grower alerts, and the one story that matters today. Sent every weekday at 7am. Free.
No spam. Unsubscribe with one click. 21+ only.
Related from Business

Stale Flower Cuts Dispensary Margins as Aging Inventory Forces Discounts
Slow-moving cannabis flower forces retailers into margin-killing markdowns, turning freshness into a financial control point.

Wholesale Cannabis Prices Drop Across U.S. Markets in 2025
Oversupply and maturing state programs continue to compress wholesale flower and concentrate margins nationwide.

Jushi Holdings Applies for DEA Registration of Medical Operations
The Pennsylvania-based MSO filed for federal registration across its state-licensed medical dispensaries, a first-mover bet on rescheduling finalization.
More from the newsroom

Hawaii Denied 47 Gun Permits to Medical Marijuana Patients in 2025
Medical cannabis registration was the top reason Hawaii rejected firearm applications last year, state attorney general data shows.

Seven House Democrats Demand IRS Issue 280E Cannabis Tax Guidance
Congressional letter pressures Treasury to clarify deduction rules amid ongoing Schedule III reclassification.

Federal Medical Marijuana Recognition Raises Implementation Questions
Agencies face regulatory gaps after historic policy shift acknowledges medical value.